COMMON STOCK PURCHASE WARRANT Nanoviricides, inc.Common Stock Purchase Warrant • January 28th, 2020 • Nanoviricides, Inc. • Services-commercial physical & biological research
Contract Type FiledJanuary 28th, 2020 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________________. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Exchange Date, subject to the availability of authorized shares of Common Stock, and on or prior to 5:00 p.m. (New York City time) on August 27, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NanoViricides, Inc., a Nevada corporation (the “Company”), up to 173,611 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXCHANGE AGREEMENTExchange Agreement • January 28th, 2020 • Nanoviricides, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledJanuary 28th, 2020 Company Industry JurisdictionEXCHANGE AGREEMENT (the "Agreement"), dated as of January 27, 2020 by and between NanoViricides, Inc., a Nevada corporation (the "Company"), the investor listed on the signature page attached hereto under the heading "Holder" (the "Holder" and together with the Company, the "Parties"). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement or the Existing Warrants (each as defined below), as applicable.
SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement and Mutual Release • January 28th, 2020 • Nanoviricides, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledJanuary 28th, 2020 Company Industry JurisdictionThis Settlement Agreement and Mutual Release (“AGREEMENT”) is entered into as of January 24, 2020 by and among Hudson Bay Master Fund Ltd., a company formed under the laws of the Cayman Islands, (“HUDSON BAY”); Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B, a company formed under the laws of the Cayman Islands (“ALTO”), and Nanoviricides, Inc., a company incorporated under the laws of Nevada (“NANOVIRICIDES” or the "COMPANY"). In this AGREEMENT, HUDSON BAY AND ALTO are collectively referred to as the "PURCHASERS," and HUDSON BAY, ALTO and NANOVIRICIDES are collectively referred to as the “PARTIES” and individually as a “PARTY.”